Optimization of a Method to Detect Autoantigen-Specific T-Cell Responses in Type 1 Diabetes

The development of tolerizing therapies aiming to inactivate autoreactive effector T-cells is a promising therapeutic approach to control undesired autoimmune responses in human diseases such as Type 1 Diabetes (T1D). A critical issue is a lack of sensitive and reproducible methods to analyze antige...

Descripción completa

Detalles Bibliográficos
Autores principales: Musthaffa, Yassmin, Nel, Hendrik J., Ramnoruth, Nishta, Patel, Swati, Hamilton-Williams, Emma E., Harris, Mark, Thomas, Ranjeny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793893/
https://www.ncbi.nlm.nih.gov/pubmed/33424839
http://dx.doi.org/10.3389/fimmu.2020.587469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793893/
https://www.ncbi.nlm.nih.gov/pubmed/33424839
http://dx.doi.org/10.3389/fimmu.2020.587469

Ejemplares similares